# Viral Therapy in Treating Patients With Metastatic Melanoma

> **NCT00651157** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 23 (actual)

## Conditions studied

- Recurrent Melanoma
- Stage IV Melanoma

## Interventions

- **BIOLOGICAL:** wild-type reovirus

## Key facts

- **NCT ID:** NCT00651157
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-12
- **Final completion:** 2012-10
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2014-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00651157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00651157, "Viral Therapy in Treating Patients With Metastatic Melanoma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00651157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*